肯尼亚疟原虫感染率与环子孢子蛋白基因多样性
该研究分析了2014至2015年肯尼亚西部663例无症状和245例有症状者的血样,发现卵形疟原虫占无症状感染的5.3%和临床病例的3.3%,且PCR检测的卵形疟原虫感染中71%未被镜检发现,环子孢子蛋白基因序列显示非洲卵形疟原虫遗传多样性高但无明确地理分化。
要点
- 卵形疟原虫在无症状感染中占5.3%,在临床病例中占3.3%。
- PCR检测的卵形疟原虫感染中71%未被显微镜检出。
- 非洲卵形疟原虫环子孢子蛋白基因遗传多样性高,但无地理分化。
核心结论
- 卵形疟原虫应纳入非洲疟疾消除策略,并需敏感且适用于现场的检测方法。
研究设计与样本
- 研究于2014年6月至8月和2015年6月至8月在肯尼亚西部采集663例无症状者和245例有症状者的血样。
主要发现
- 卵形疟原虫占无症状感染的5.3%(35/663),占临床病例的3.3%(8/245)。
- 无症状者中,PCR检测的卵形疟原虫感染有71%(32/45)未被显微镜检出。
- 显微镜低敏感性可能源于卵形疟原虫血症水平显著较低。
- 卵形疟原虫环子孢子蛋白基因序列分析显示非洲卵形疟原虫遗传多样性高,但地理种群间无明确分化。
临床怎么用
- 在疟疾流行区识别卵形疟原虫需采用敏感的分子检测方法,仅靠显微镜可能漏诊多数无症状感染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In Africa, control programs that target primarily Plasmodium falciparum are inadequate for eliminating malaria. To learn more about prevalence and genetic variability of P. malariae in Africa, we examined blood samples from 663 asymptomatic and 245 symptomatic persons from western Kenya during June-August of 2014 and 2015. P. malariae accounted for 5.3% (35/663) of asymptomatic infections and 3.3% (8/245) of clinical cases. Among asymptomatic persons, 71% (32/45) of P. malariae infections detected by PCR were undetected by microscopy. The low sensitivity of microscopy probably results from the significantly lower parasitemia of P. malariae. Analyses of P. malariae circumsporozoite protein gene sequences revealed high genetic diversity among P. malariae in Africa, but no clear differentiation among geographic populations was observed. Our findings suggest that P. malariae should be included in the malaria elimination strategy in Africa and highlight the need for sensitive and field-applicable methods to identify P. malariae in malaria-endemic areas.
引用
- Lo E, Nguyen K, Nguyen J, et al. Plasmodium malariae Prevalence and csp Gene Diversity, Kenya, 2014 and 2015. Emerg Infect Dis. 2017. PMID: 28322694. doi:10.3201/eid2304.161245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。